Gilead Sciences Income from Continuous Operations 2010-2024 | GILD

Gilead Sciences income from continuous operations for the twelve months ending June 30, 2024 was $1.033B, a 81.02% decline year-over-year.

  • Gilead Sciences annual income from continuous operations for 2023 was $5.612B, a 22.91% increase from 2022.
  • Gilead Sciences annual income from continuous operations for 2022 was $4.566B, a 26.37% decline from 2021.
  • Gilead Sciences annual income from continuous operations for 2021 was $6.201B, a 6867.42% increase from 2020.

Gilead Sciences Income from Continuous Operations 2010-2024 | GILD

  • Gilead Sciences annual income from continuous operations for 2023 was $5.612B, a 22.91% increase from 2022.
  • Gilead Sciences annual income from continuous operations for 2022 was $4.566B, a 26.37% decline from 2021.
  • Gilead Sciences annual income from continuous operations for 2021 was $6.201B, a 6867.42% increase from 2020.